calina-d 2
51. Natural Coumarins: Exploring the Pharmacological Complexity and Underlying Molecular Mechanisms
52. Paclitaxel: Application in Modern Oncology and Nanomedicine-Based Cancer Therapy
53. Phenolic compounds as Nrf2 inhibitors: potential applications in cancer therapy
54. Recent advances in the therapeutic potential of emodin for human health
55. Santalum Genus: Phytochemical constituents, biological activities and health promoting-effects
56. Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
57. Global burden of lower respiratory infections and aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
58. Chemotherapeutic properties and side-effects associated with the clinical practice of terpene alkaloids: paclitaxel, docetaxel, and cabazitaxel
59. Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023
60. Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
61. Urtica dioica -Derived Phytochemicals for Pharmacological and Therapeutic Applications
62. Cucurbitacins as potential anticancer agents: new insights on molecular mechanisms
63. Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019
64. A comprehensive review on traditional uses, phytochemistry and pharmacological properties of Paeonia emodi Wall. ex Royle: current landscape and future perspectives
65. Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019
1 2 2